LIN PATRICK (Chief Business - Strategy Off) purchased 40.8% of their position (1.37K shares) of PROCESSA PHARMACEUTICALS, INC. on the open market
Open‑market purchase worth $4.1K — a major conviction buy. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 4/17/2026ACC: 0000897069-26-000908
Officer· Chief Business - Strategy Off
Since Oct 2020
+1.37K
Net shares
Net buyer
$4.1K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
1.37K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+1.37K
Price / share
$2.97
Trade value
$4.07K
% of position
40.8%
4/15/2026
3.36K→4.72K
Total
Net shares
+1.37K
Net value
$4.07K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 4/15/2026 | P · Purchase | +1.37K | $2.97 | $4.07K | 40.8% | 3.36K | 4.72K |
| Total | +1.37K | $4.07K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned1.74K
Total
1.74K indirect1.74K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 1.74K | Indirect |
| Total | 1.74K | 1.74K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported